Related Experiment Video
Updated: May 24, 2026

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
Published on: April 16, 2019
Dexamethasone therapy for bacterial meningitis: Better never than late?
1Division of Infectious Disease, Departments of Pediatrics and Audiology, Hospital for Sick Children and University of Toronto, Toronto, Ontario; Division of Infectious Diseases, The Health Sciences Centre, Winnipeg, Manitoba; and Division of Infectious Diseases, The Izaak Walton Killam Hospital, Halifax, Nova Scotia.
Insights
Dexamethasone did not significantly improve outcomes for children with bacterial meningitis. Early administration of dexamethasone with antibiotics is recommended if used, as delayed treatment showed no benefit.
Area of Science:
- Pediatrics
- Infectious Diseases
- Clinical Trials
Background:
- Bacterial meningitis is a serious infection in children.
- Dexamethasone is a corticosteroid that may reduce inflammation and complications.
Purpose of the Study:
- To evaluate the efficacy of dexamethasone in reducing hearing loss and neurological abnormalities in children with bacterial meningitis.
Main Methods:
- A multicentre randomized controlled trial compared dexamethasone to placebo in children with bacterial meningitis.
- Treatment lasted four days, initiated within 24 hours of antibiotics.
- Outcomes (hearing loss, neurological deficits) were assessed at 12 months.
Main Results:
- No significant difference in hearing loss (10% vs. 11%) or neurological deficits (20% vs. 18%) between groups.
- One case of duodenal perforation occurred in the dexamethasone group.
- Delayed dexamethasone administration (median 11 hours) may explain the lack of benefit.
Conclusions:
- Dexamethasone did not demonstrate significant benefit for children with bacterial meningitis in this trial.
- Immediate administration of dexamethasone concurrently with antibiotics is suggested for potential efficacy.
- Further research may be needed to clarify the optimal timing and role of dexamethasone in bacterial meningitis treatment.
Abstract:
A multicentre randomized controlled trial was conducted in children with bacterial meningitis using dexamethasone or placebo for four days within 24 h of starting antibiotics. Primary outcomes were hearing loss and neurological abnormalities at 12 months after meningitis. The dexamethasone (n=50) and placebo (n=51) groups were similar in age, severity of illness and etiological agent. Hearing loss occurred in 10% and 11% of the dexamethasone and placebo groups and neurological deficits occurred in 20% and 18% of patients, respectively. Duodenal perforation occurred in one dexamethasone-treated child. In conclusion, there was no significant benefit in those receiving dexamethasone. The lack of benefit may have been due to the delay in administration of dexamethasone (median delay of 11 h after antibiotics). Therefore, if dexamethasone is used for meningitis it should be given immediately with the antibiotic.
Related Concept Videos
Diphtheria
Bacterial Meningitis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Bacterial Meningitis II: Pathophysiology
Viral Meningitis
Brain Abscess l: Introduction